A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects

NCT01597713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2
Healthy

Interventions

DRUG: NNC 0148-0000-0362
DRUG: insulin glargine
DRUG: placebo
DRUG: NNC 0148-0000-0362
DRUG: NNC 0148-0000-0362
DRUG: NNC 0148-0000-0362

Sponsor

Novo Nordisk A/S